Devonian Health Group Inc Appoints Dr. Jean-Claude Tardif as Chairman of Scientific Advisory Board

November 7, 2016

M. André Boulet, President, CEO and Chairman of Devonian Health Group Inc a pharmaceutical company based in Québec Canada and Benoit Chotard, President of Orletto Capital inc., are pleased to announce the appointment of Dr. Jean-Claude Tardif, CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS as Chairman of the Scientific Advisory Board ("SAB") of Devonian, which will serve as a strategic resource to Devonian as it advances its clinical program.

Read more

An extraordinary gift: The Saputo family donates $10 million to the MHI for prevention

September 9, 2016

Thanks to the exceptional gift from the Saputo family, the Montreal Heart Institute (MHI) will be able to pursue its investments in prevention and will proceed with a major expansion, planned to begin in the fall of 2016.

Read more